CBT for tinnitus related insomnia
- Conditions
- Chronic Tinnitus
- Registration Number
- NL-OMON24403
- Lead Sponsor
- Maastricht University Faculty of Psychology and Neuroscience
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 6
In order to be eligible to participate in this study, a subject must meet all of the following criteria:
- Be primarily seeking treatment/help for difficulties caused by tinnitus.
- Additionally complaints of sleep disturbance (e.g. insomnia) as measured by the Insomnia Severity Index.
- Recommended to start CBTi protocol.
- Be at least 18 years of age. - Have at least moderate tinnitus (as defined by the Tinnitus Questionnaire)
- Any person who discloses current suicidal intent.
- Severe anxiety or depression (as measured by the HADS-A and/or HADS-D.)
- Pregnancy of potential participant or partner.
- Currently undergoing any treatment for tinnitus (e.g. Tinnitus Retraining Therapy).
- Reported to have commenced or ceased a course of antidepressants [i.e. selective serotonin re-uptake inhibitors (SSRIs); selective serotonin and norepinephrine re-uptake inhibitors (SNRIs); atypical antidepressants, tricyclic antidepressants, or monoamine oxidase inhibitors], antipsychotics [Aripiprazole (Abilify), Asenapine (Saphris), Brexpiprazole (Rexulti), Cariprazine (Vraylar), Clozapine (Clozaril), Iloperidone (Fanapt), Lurasidone (Latuda), Olanzapine (Zyprexa), Paliperidone (Invega), Quetiapine (Seroquel), Risperidone (Risperdal), Ziprasidone (Geodon), Haloperidol], anxioltytics [beta blockers, benzodiazepines], Ritalin, hormone replacement therapy, or medication to lower high blood pressure (i.e. thiazide diuretics, ACE inhibitors, angiotensin II receptor blockers, beta blockers, calcium channel blockers, renin inhibitors] within the previous 3 months
- Unable to read and write fluently in Dutch.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sleep quality as measured by the sleep diary
- Secondary Outcome Measures
Name Time Method Tinnitus experience as measured by the tinnitus diary